drugset
drugset / Trial / NCT03411850

Sjogrens Syndrome Measured by Ultrasound

NCT03411850 ↗

Phase 2 Unknown 20 enrolled Arthritis & Rheumatism Associates, P.C. Bristol-Myers Squibb · collab
RandomizedCrossoverSingle-blindOther

Summary

Ultrasound study focused on salivary gland outcomes in Sjogren's subjects

Timeline

Start
2016-05
Primary completion
2021-05
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Abatacept Other / unclassified — Intravenous

Indications

Sjogren syndrome